List view / Grid view

Dalip Sethi (Terumo Blood and Cell Technologies)

 

article

Overcoming operational challenges in CGT manufacturing with AI

In this Q&A, Dalip Sethi, scientific lead for Terumo Blood…

18 September 2024 | By

In this Q&A, Dalip Sethi, scientific lead for Terumo Blood and Cell Technologies, Cell Therapy Technologies and Innovation portfolio, discusses the integration of AI into CGT manufacturing processes to enhance operational efficiency and accelerate treatment access. He also elucidates the strategies that are being considered to overcome hurdles when implementing…